Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXF6SX
|
||||
Drug Name |
rac-9-(cyclohexylmethyl)-5-methyl-12-(tetrahydro-2H-pyran-2-yl)-5,7,8,9-tetrahydro-1H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-3(2H)-one
|
||||
Synonyms |
CHEMBL1085292
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C32H36N4O2
|
||||
Canonical SMILES |
Cn1cc2c(CCc3c2c4C(=O)NCc4c5c6cc(ccc6n(CC7CCCCC7)c35)C8CCCCO8)n1
|
||||
InChI |
InChI=1S/C32H36N4O2/c1-35-18-24-25(34-35)12-11-21-28(24)30-23(16-33-32(30)37)29-22-15-20(27-9-5-6-14-38-27)10-13-26(22)36(31(21)29)17-19-7-3-2-4-8-19/h10,13,15,18-19,27H,2-9,11-12,14,16-17H2,1H3,(H,33,37)
|
||||
InChIKey |
YOSNZLGNAZKSBX-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
Angiopoietin 1 receptor | Target Info | [1587926] | |||
NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
VEGF signaling pathwayP00005:Angiogenesis | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
Beta3 integrin cell surface interactions | |||||
Signaling events mediated by TCPTP | |||||
SHP2 signaling | |||||
S1P1 pathway | |||||
VEGF and VEGFR signaling network | |||||
Integrins in angiogenesis | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.